Dudediligence.

Schrödinger, Inc

SDGRNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$35.3MSep ’24$88.3MDec ’24$59.6MMar ’25$54.8MJun ’25$54.3MSep ’25$87.2MDec ’25$58.6MMar ’26$58.9MJun ’26
Net income, by quarter
−$38.1MSep ’24−$40.2MDec ’24−$59.8MMar ’25−$43.2MJun ’25−$32.8MSep ’25$32.5MDec ’25−$60.0MMar ’26$6.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$137.9M$181.0M$216.7M$207.5M$255.9M
Gross profit$65.6M$101.0M$140.7M$132.1M$142.6M
Operating income−$111.4M−$146.8M−$177.4M−$209.3M−$166.9M
Net income−$100.4M−$149.2M$40.7M−$187.1M−$103.3M
Operating cash flow−$70.7M−$119.7M−$136.7M−$157.4M$13.9M
Free cash flow−$77.8M−$127.7M−$150.1M−$164.7M$12.5M
Cash$120.3M$90.5M$155.3M$147.3M$230.5M
Shares outstanding61.8M62.2M63.0M72.7M73.4M